1. Latest News
  2. Submit Press Release

DCA and Radiation Effect Complete Long Term Remission of Previously 'Incurable' Cancer

DCA in conjunction with radiation led to a long term (5 year) remission in a cancer (Renal squamous cell carcinoma (“RSCC”)) which was previously considered untreatable and incurable in the field.

Nov. 7, 2012 - PRLog -- Dicholoracetate (DCA) received much media attention in 2007 when Evangelos Michelakis of the University of Alberta reported that it dramatically shrank tumours across a broad spectrum of cancers in mice.  The media stir had patients clamouring for the drug before it passed the traditional trials.  Michelakis’ warning (amongst others) against taking the drug before the trials fell on deaf ears with a spate of online sites springing up selling the cheap, relatively simple, and generally well tolerated substance.

There was a big problem with DCA which had nothing to do with its pharmacology;  It wasn’t patentable.  To bring a drug to market, it costs a pharmaceutical company in the neighbourhood of a billion dollars which means that a watertight patent is required to ensure that the company receives return on investment.  As such, the drug was largely ignored by the mainstream pharmaceutical market.

To read the full release, please visit:


--- End ---

Click to Share

Contact Email:
***@martincwiner.com Email Verified
Location:Vaughan - Ontario - Canada
Industry:Biotech, Health, Medical
Tags:Dca, RSCC
Verified Account Email Address
Verified Account Phone Number

Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Latest Press Releases By “


Like PRLog?
Click to Share